Literature DB >> 3156808

Augmentation of cell-mediated responses in vitro by a monoclonal anti-helper factor antibody.

R F James, G H Sunshine, S Edwards, D J Maudsley, M Feldmann.   

Abstract

Previous studies have shown that monoclonal antibody AF3.44.4 has specificity for a constant region determinant on mouse antigen-specific helper factors and that it also binds to cultured T cells with functional helper cell characteristics. The antibody synergizes with antigen to enhance in vitro antibody responses; here we demonstrate that it will also enhance cell-mediated responses in vitro such as in the generation of proliferating cells in mixed lymphocyte responses and in the generation of specific killer cells in cytotoxic T lymphocyte cultures. The mechanism of AF3.44.4-generated enhancement was investigated. Increased levels of the lymphokines IL-2 and BCDF were detected in supernatants of AF3.44.4-treated cultures but the antibody itself could not replace interleukin-2 (IL-2), and would not stimulate primed cells in the absence of antigen. This type of monoclonal antibody which augments immunological responses in an antigen-dependent fashion may provide a new class of immunostimulant and a new approach to augmenting the responses of weak immunogens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156808      PMCID: PMC1453569     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

Review 2.  The role of antigen-specific T cell factors in the immune response.

Authors:  T Tada; K Okumura
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells.

Authors:  S Kontiainen; M Feldmann
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

6.  Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors.

Authors:  A A Czitrom; G H Sunshine; T Reme; R Ceredig; A L Glasebrook; A Kelso; H R MacDonald
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.

Authors:  J Shaw; B Caplan; V Paetkau; L M Pilarski; T L Delovitch; I F McKenzie
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

Review 8.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

9.  Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

10.  Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Authors:  C Hardt; M Röllinghoff; K Pfizenmaier; H Mosmann; H Wagner
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  1 in total

1.  Inhibition of expression of cell-mediated immunity by a cell surface-binding antibody directed against T-cell helper factors.

Authors:  L S Anthony; R F James; D J Maudsley; P A Kongshavn
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.